Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7289 USD | -2.68% | +2.71% | +27.25% |
03-14 | Vaxart, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-14 | Transcript : Vaxart, Inc., 2023 Earnings Call, Mar 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.25% | 129M | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- VXRT Stock
- News Vaxart, Inc.
- Vaxart : Investigational New-Drug Application for COVID-19 Vaccine Candidate Receives FDA Approval; Shares Rise